Source: Enthusiast Gaming.
  • Enthusiast Gaming (EGLX) has secured Campbell Company of Canada as its new media sponsor
  • Campbell’s Chunky Soup will serve as presenting sponsor for NFL Tuesday Night Gaming’s Chunky Soup Showdown on Tuesday, January 24, 2023
  • The custom content activation will see NFL players and legends face off live against top content creators, MMG and UpAndAdam, in a tournament format
  • Enthusiast Gaming Holdings is an integrated gaming entertainment company
  • Enthusiast Gaming (EGLX) is down by 1.04 per cent, trading at $0.95 per share

Enthusiast Gaming (EGLX) has secured Campbell Company of Canada as its new media sponsor.

Campbell’s Chunky Soup will serve as presenting sponsor for NFL Tuesday Night Gaming’s Chunky Soup Showdown on Tuesday, January 24, 2023.

The program is a custom content activation that will see NFL players and legends face off live against top content creators, MMG and UpAndAdam, in a tournament format.

The activation will include product placement and exclusive owned moments supported across Enthusiast’s assets.

The tournament will air on NFL Tuesday Night Gaming’s YouTube and Twitter channels.

“Our bespoke and integrated solutions, consisting of custom content, talent and premium media inventory, continue to solve an important need for brands looking to reach Gen Z and millennial audiences in an authentic way and at scale,” stated Bill Karamouzis, President of Enthusiast Gaming.

Enthusiast Gaming Holdings is an integrated gaming entertainment company building the largest media and content platform for video game and esports fans to connect and engage worldwide.

Enthusiast Gaming (EGLX) is down by 1.04 per cent, trading at $0.95 per share as of 1:01 pm EST.


More From The Market Online

From robotic limbs to new highs, NVIDIA stock is on a roll

NVIDIA Corp. (NDAQ:NVDA; NEO:NVDA) opens Tuesday trading on a positive note, showing a significant upward trend.

Western Alaska Minerals begins drilling in Alaska

Western Alaska Minerals (TSXV:WAM) begins drilling at its 100-per-cent-owned Illinois Creek property in Western Alaska.

Theralase adds cancer immunotherapy to potential revenue streams

Theralase Technologies' (TSXV:TLT) lead drug candidate, Rutherrin, enhanced cancer immunotherapy in a pre-clinical setting.